解剖性切除在1期典型类癌患者的总生存方面优于楔形切除
该研究基于欧洲胸外科医师学会肺神经内分泌肿瘤工作组的回顾性数据库,分析876例1期典型类癌患者的手术方式对生存的影响。中位年龄60岁,女性569例(65%),5年总生存率为94.3%(95%CI 92.2-95.9)。多分类倾向性评分分析显示,与肺叶切除相比,楔形切除患者的生存显著更差(HR 2.01,95%CI 1.09-3.69;P=0.024)。
要点
- 876例1期典型类癌患者中,5年总生存率为94.3%(95%CI 92.2-95.9)。
- 与肺叶切除相比,楔形切除与更差的总生存显著相关(HR 2.01,95%CI 1.09-3.69;P=0.024)。
- 肿瘤相关死亡(HR 2.28,95%CI 0.86-6.02;P=0.096)和非肿瘤相关死亡(HR 1.74,95%CI 0.89-3.40;P=0.105)中楔形切除的效应未达统计学显著。
核心结论
- 在1期典型类癌患者中,解剖性手术切除在总生存方面优于楔形切除,该结果应考虑用于未来典型类癌管理的临床指南。
研究设计与样本
- 基于欧洲胸外科医师学会肺神经内分泌肿瘤工作组回顾性数据库,分析手术方式对1期典型类癌患者生存的影响,共纳入876例患者(女性569例,65%),中位年龄60岁(四分位距47-69)。
- 总生存从干预日期起计算,并估计肿瘤相关和非肿瘤相关死亡的累积发生率。
- 采用Cox模型(共享脆弱性模型,针对总生存,考虑中心内相关性)和Fine and Gray模型(针对病因特异性死亡)分析手术方式(肺叶切除 vs 肺段切除 vs 楔形切除)的影响,使用基于多分类倾向性评分的方法,模型中纳入肺段切除和楔形切除的logit转换倾向性评分作为协变量。
主要发现
- 末次随访时66例患者死亡,5年总生存率为94.3%(95%CI 92.2-95.9)。
- 5年肿瘤相关死亡累积发生率为2.4%(95%CI 1.4-3.9),非肿瘤相关死亡累积发生率为3.9%(95%CI 2.5-5.6)。
- 多分类倾向性评分分析证实,与肺叶切除相比,楔形切除患者生存显著更差(HR 2.01,95%CI 1.09-3.69;P=0.024)。
- 肿瘤相关死亡(HR 2.28,95%CI 0.86-6.02;P=0.096)和非肿瘤相关死亡(HR 1.74,95%CI 0.89-3.40;P=0.105)中楔形切除的效应未达统计学显著。
临床怎么用
- 作者认为,在1期典型类癌患者中解剖性手术切除在总生存方面优于楔形切除,该结果应考虑用于未来典型类癌管理的临床指南。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Typical carcinoids (TCs) are rare, slow-growing neoplasms, usually characterized by satisfactory surgical outcomes. Due to the rarity of TCs, international guidelines for the management of particular clinical presentations currently do not exist. In particular, non-anatomical resections (wedges) are sometimes advocated for Stage 1 TCs because of their indolent behaviour. The aim of this paper was to evaluate the most effective type of surgery for Stage 1 TCs, using the European Society of Thoracic Surgeons retrospective database of the Neuroendocrine Tumors of the Lung Working Group. METHODS: We analysed the effect of surgical procedure on the survival of patients with Stage 1 TCs. Overall survival (OS) was calculated from the date of intervention. The cumulative incidence of cause-specific death (tumour- and non-tumour-related) was also estimated. The impact of the surgical procedure (i.e. lobectomy vs segmentectomy vs wedge resection) on survival was investigated using the Cox model with shared frailty (for OS, accounting for the within-centre correlation) and the Fine and Gray model (for cause-specific mortality) using the approach based on the multinomial propensity score. Effects were estimated including in the model the logit-transformed propensity scores of segmentectomy and wedge resection as covariates. RESULTS: A total of 876 patients with Stage 1 TCs (569 women, 65%) were included in this study. The median age was 60 years (interquartile range 47-69). At the last follow-up, 66 patients had died: The 5-year OS rate was 94.3% [95% confidence interval (CI) 92.2-95.9]. The 5-year cumulative incidences of tumour- and non-tumour-related deaths were 2.4% (95% CI 1.4-3.9) and 3.9% (95% CI 2.5-5.6%), respectively. The analysis performed using the multinomial propensity score approach confirmed the significantly worse survival of patients treated with a wedge resection compared to those treated with a lobectomy (hazard ratio 2.01, 95% CI 1.09-3.69; P = 0.024). Similar effects of wedge resection are detectable for cause-specific deaths: tumour-related (hazard ratio 2.28, 95% CI 0.86-6.02; P = 0.096) and non-tumour-related (hazard ratio 1.74, 95% CI 0.89-3.40; P = 0.105). CONCLUSIONS: In a large cohort of patients, we were able to demonstrate the superiority of anatomical surgical resection in Stage 1 TCs in terms of OS. This result should therefore be considered for future clinical guidelines for the management of TCs.
引用
- Filosso PL, Guerrera F, Falco NR, et al. Anatomical resections are superior to wedge resections for overall survival in patients with Stage 1 typical carcinoids. Eur J Cardiothorac Surg. 2019. PMID: 30032287. doi:10.1093/ejcts/ezy250
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。